← Leaderboards
Daryl Ewald Klein
Yale University
$2,319,274
Attributed
$2,319,274
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $383.2K · FY2017–24$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,319,274 · 2
By mechanism
R01$1,888,960 · 1
K22$430,314 · 1
Top collaborators
No co-investigators on record.
Most similar at Yale University
Same institution · by research overlap
- Erol Fikrig$57,005,638
- Jennifer A Doudna$26,483,799
- Michael J. Caplan$23,440,704
- Jeffrey R. Bender$22,395,373
- Frederick H Wilson$1,318,509
Others in their field
Other Emerging Leaders on “Oncogenic”
- Rachana Agarwal · Leidos Biomedical Research, Inc.$15,241,462
- J. Silvio Gutkind · University Of California, San Diego$8,361,873
- Leonard Freedman · Leidos Biomedical Research, Inc.$7,415,725
- Paul Northcott · St. Jude Children'S Research Hospital$6,629,307
- Wenbo Li · University Of Texas Hlth Sci Ctr Houston$6,041,291
- Poulikos I Poulikakos · Icahn School Of Medicine At Mount Sinai$5,408,309
Research focus
OncogenicSignal PathwayLigandsMutationReceptor ActivationResponseDimerLengthMalignant NeoplasmsMutantProteinsReceptorReceptor Protein-Tyrosine KinasesReceptor SignalingAffectBiophysicsExtracellularInsightDesignLogicMolecularMonoclonal AntibodiesEmbryonic DevelopmentSignal Transduction
Grant awards (8)
Identifying opportunities for extracellular inhibition of ALK signaling$363,999
R01 · FY2024 · CA · contact PI
Identifying opportunities for extracellular inhibition of ALK signaling$375,493
R01 · FY2023 · CA · contact PI
Identifying opportunities for extracellular inhibition of ALK signaling$383,156
R01 · FY2022 · CA · contact PI
Identifying opportunities for extracellular inhibition of ALK signaling$383,156
R01 · FY2021 · CA · contact PI
Identifying opportunities for extracellular inhibition of ALK signaling$383,156
R01 · FY2020 · CA · contact PI
Harnessing receptor pleiotropy to control cancer$143,438
K22 · FY2019 · CA · contact PI
Harnessing receptor pleiotropy to control cancer$143,438
K22 · FY2018 · CA · contact PI
Harnessing receptor pleiotropy to control cancer$143,438
K22 · FY2017 · CA · contact PI